KR101664290B1 - 비관절염 포유동물의 운동으로 유발된 관절 통증을 감소시키는 방법 - Google Patents

비관절염 포유동물의 운동으로 유발된 관절 통증을 감소시키는 방법 Download PDF

Info

Publication number
KR101664290B1
KR101664290B1 KR1020147010693A KR20147010693A KR101664290B1 KR 101664290 B1 KR101664290 B1 KR 101664290B1 KR 1020147010693 A KR1020147010693 A KR 1020147010693A KR 20147010693 A KR20147010693 A KR 20147010693A KR 101664290 B1 KR101664290 B1 KR 101664290B1
Authority
KR
South Korea
Prior art keywords
collagen
pharmaceutical composition
joint pain
type
pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020147010693A
Other languages
English (en)
Korean (ko)
Other versions
KR20150059132A (ko
Inventor
폴 디즈크스트라
프란시스 씨. 라우
제임스 루고
자이눌라베딘 엠. 사이예드
Original Assignee
인터헬쓰 뉴트라슈티칼즈 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 인터헬쓰 뉴트라슈티칼즈 인코포레이티드 filed Critical 인터헬쓰 뉴트라슈티칼즈 인코포레이티드
Publication of KR20150059132A publication Critical patent/KR20150059132A/ko
Application granted granted Critical
Publication of KR101664290B1 publication Critical patent/KR101664290B1/ko
Assigned to 론자 그린우드 엘엘씨 reassignment 론자 그린우드 엘엘씨 권리의 전부이전등록 Assignors: 론자 컨슈머 헬스 인크.
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020147010693A 2013-10-24 2014-01-13 비관절염 포유동물의 운동으로 유발된 관절 통증을 감소시키는 방법 Active KR101664290B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361895332P 2013-10-24 2013-10-24
US61/895,332 2013-10-24
PCT/US2014/011303 WO2015060888A1 (en) 2013-10-24 2014-01-13 Method of reducing exercise-induced joint pain in non-arthritic mammals

Publications (2)

Publication Number Publication Date
KR20150059132A KR20150059132A (ko) 2015-05-29
KR101664290B1 true KR101664290B1 (ko) 2016-10-11

Family

ID=51610711

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147010693A Active KR101664290B1 (ko) 2013-10-24 2014-01-13 비관절염 포유동물의 운동으로 유발된 관절 통증을 감소시키는 방법

Country Status (14)

Country Link
US (1) US9066926B2 (enExample)
KR (1) KR101664290B1 (enExample)
AR (1) AR095104A1 (enExample)
AU (1) AU2014202041B8 (enExample)
BR (1) BR112014011741A2 (enExample)
CA (1) CA2846644C (enExample)
CL (1) CL2014001281A1 (enExample)
CO (1) CO7020846A2 (enExample)
IN (1) IN2014DE00193A (enExample)
MX (1) MX347669B (enExample)
MY (1) MY180106A (enExample)
PH (1) PH12014501453A1 (enExample)
SG (1) SG11201403524RA (enExample)
WO (1) WO2015060888A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20260006191A (ko) 2024-07-04 2026-01-13 씨엔에이바이오텍(주) 비변성 ⅱ형 콜라겐 제조방법 및 그의 제조방법에 따라 제조되는 비변성 ⅱ형 콜라겐

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10226513B2 (en) 2015-01-09 2019-03-12 Mark Terrell Smith Method and composition to prevent or improve symptoms of musculoskeletal distress degeneration
AU2017325823A1 (en) * 2016-09-16 2019-05-02 Boston Scientific Neuromodulation Corporation System for pain management using heart sounds
WO2018063912A1 (en) 2016-09-27 2018-04-05 Boston Scientific Neuromodulation Corporation Systems and methods for closed-loop pain management
AU2017335497B2 (en) 2016-09-27 2020-01-16 Boston Scientific Neuromodulation Corporation System for pain management using objective pain measure
US11793217B1 (en) 2016-10-04 2023-10-24 Lonza Greenwood Llc Method of manufacture and pasteurization of products containing undenatured collagen
US11850324B2 (en) 2016-10-12 2023-12-26 Advanced Biomatrix, Inc. Three-dimensional (3-D) printing inks made from natural extracellular matrix molecules
WO2018080887A1 (en) 2016-10-25 2018-05-03 Boston Scientific Neuromodulation Corporation System for pain management using baroreflex sensitivity
US10631777B2 (en) 2017-01-11 2020-04-28 Boston Scientific Neuromodulation Corporation Pain management based on functional measurements
US10729905B2 (en) 2017-01-11 2020-08-04 Boston Scientific Neuromodulation Corporation Pain management based on muscle tension measurements
US11089997B2 (en) 2017-01-11 2021-08-17 Boston Scientific Neuromodulation Corporation Patient-specific calibration of pain quantification
EP3568069B1 (en) 2017-01-11 2021-04-28 Boston Scientific Neuromodulation Corporation Pain management based on brain activity monitoring
US10926091B2 (en) 2017-01-11 2021-02-23 Boston Scientific Neuromodulation Corporation Pain management based on emotional expression measurements
US10631776B2 (en) 2017-01-11 2020-04-28 Boston Scientific Neuromodulation Corporation Pain management based on respiration-mediated heart rates
US10960210B2 (en) 2017-02-10 2021-03-30 Boston Scientific Neuromodulation Corporation Method and apparatus for pain management with sleep detection
CN106713191B (zh) * 2017-02-28 2020-09-08 西安电子科技大学 一种多级搜索sage方法
CN107048412A (zh) * 2017-04-26 2017-08-18 北京盛美诺生物技术有限公司 一种含有ⅱ型胶原蛋白的咀嚼型产品
AU2018304079B2 (en) 2017-07-18 2020-12-03 Boston Scientific Neuromodulation Corporation Sensor-based pain management systems and methods
US20190054152A1 (en) * 2017-08-21 2019-02-21 Lonza Inc. Composition and Nutritional Supplement Made Therefrom
US20190060415A1 (en) * 2017-08-31 2019-02-28 Lonza Inc. Health promoting composition and methods of use supplement
IT201700111939A1 (it) * 2017-10-05 2019-04-05 Jointherapeutics S R L Composizione farmaceutica per l’uso nel trattamento di stati infiammatori
CA3106630A1 (en) * 2018-07-16 2020-01-23 Lonza Consumer Health Inc. Collagen and cell matter supplement and method for administering same
WO2021016665A1 (en) * 2019-07-30 2021-02-04 Atp Institute Pty Ltd A gummy composition
WO2021067452A1 (en) * 2019-09-30 2021-04-08 Lonza Consumer Health Inc. Cannabinoid product for improving musculoskeletal health
BR112022014911A2 (pt) 2020-01-29 2022-09-20 Lonza Consumer Health Inc Composição de saúde articular e uso da mesma em mamíferos saudáveis
CN115379762A (zh) 2020-03-03 2022-11-22 龙沙格林伍德有限公司 食物和饮料应用中的非变性ii型胶原蛋白和其用途
WO2021195068A1 (en) 2020-03-24 2021-09-30 Lonza Consumer Health Inc. Undenatured type ii collagen in animal food and treats
EP4146251A1 (en) 2020-06-12 2023-03-15 Lonza Greenwood LLC Undenatured type ii collagen as a supplement for improved endurance, lipid metabolism, and oxidative stress
WO2022040026A1 (en) * 2020-08-19 2022-02-24 Lonza Consumer Health Inc. Method for improving inflammation, joint health, joint mobility, and joint comfort in healthy mammals
CN115120618B (zh) * 2021-03-23 2024-01-26 安徽盛美诺生物技术有限公司 具有改善免疫应答作用的软骨提取物、其制备方法及其用途
KR20240101672A (ko) * 2021-11-12 2024-07-02 론자 그린우드 엘엘씨 골격 관절의 치료 방법 및 이의 조성물 및 용도
KR102771944B1 (ko) * 2023-09-25 2025-02-26 (주)온오퍼 고함량 액티브 성분을 갖는 반려동물용 츄 형태 영양제
WO2026006443A1 (en) * 2024-06-25 2026-01-02 Viscus Biologics, Llc Nutritional joint health supplement compositions and methods for making and using same

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110218151A1 (en) 2010-03-04 2011-09-08 Joar Opheim Substances for promoting healthy joint function comprising omega-3 polyunsaturated fatty acids or drivatives thereof, undenatured type ii collagen and, optionally, glucosamine sulfate

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399347A (en) 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
AU2800492A (en) 1991-11-08 1993-06-07 Gunilla Lofgren Nisser Partially occluded contact lens for treating visual and/or brain disorder
US5645851A (en) 1994-02-28 1997-07-08 Moore; Eugene R. Product for alleviating the symptons of arthritis in mammals
US5637321A (en) 1994-02-28 1997-06-10 Moore; Eugene R. Method for preparing animal tissue for use in alleviating the symptoms of arthritis in mammals
US5529786A (en) 1994-02-28 1996-06-25 Moore; Eugene R. Process and product for treatment of rheumatoid arthritis
US6162787A (en) 1999-04-02 2000-12-19 Immudyne, Inc. Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions
US6372794B1 (en) * 1999-08-26 2002-04-16 Marcel E. Nimni Method for alleviating arthritis in mammals
US20020086070A1 (en) 2000-03-11 2002-07-04 Kuhrts Eric Hauser Anti-inflammatory and connective tissue repair formulations
US7083820B2 (en) 2000-09-29 2006-08-01 Schilling Marvin L Method for producing biologically active products
JP2003048850A (ja) 2001-06-01 2003-02-21 Nippon Meat Packers Inc 関節傷害治療剤及び機能性食品
US20060062859A1 (en) * 2004-08-05 2006-03-23 Kenneth Blum Composition and method to optimize and customize nutritional supplement formulations by measuring genetic and metabolomic contributing factors to disease diagnosis, stratification, prognosis, metabolism, and therapeutic outcomes
FR2900155B1 (fr) * 2006-04-21 2008-06-27 Diana Naturals Sa Hydrolisat de cartilage aviaire, procede d'obtention et utilisations
US20100215731A1 (en) 2009-02-20 2010-08-26 Maastricht University Method for improving cartilage repair and/or preventing cartilage degeneration in a joint
CN101822684B (zh) 2010-05-27 2012-08-15 江苏江山制药有限公司 用于防治骨关节痛的复方组合制剂及其制备方法
US20120294898A1 (en) 2011-05-19 2012-11-22 Warsaw Orthopedic, Inc. Injectable dbm for soft tissue repair
CN102423487B (zh) 2011-12-23 2014-04-16 内蒙古伊利实业集团股份有限公司 一种骨关节保健组合物及其应用
CN103203012A (zh) 2012-01-12 2013-07-17 深圳市麦金利实业有限公司 关节保健品

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110218151A1 (en) 2010-03-04 2011-09-08 Joar Opheim Substances for promoting healthy joint function comprising omega-3 polyunsaturated fatty acids or drivatives thereof, undenatured type ii collagen and, optionally, glucosamine sulfate

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J. vet. Pharmacol. Therap., 제32권 제577-584면, 2009년.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20260006191A (ko) 2024-07-04 2026-01-13 씨엔에이바이오텍(주) 비변성 ⅱ형 콜라겐 제조방법 및 그의 제조방법에 따라 제조되는 비변성 ⅱ형 콜라겐

Also Published As

Publication number Publication date
AU2014202041B8 (en) 2020-04-02
MX2014002934A (es) 2015-09-21
AR095104A1 (es) 2015-09-30
CL2014001281A1 (es) 2015-10-30
WO2015060888A1 (en) 2015-04-30
SG11201403524RA (en) 2015-05-28
US20150119335A1 (en) 2015-04-30
PH12014501453B1 (en) 2015-01-21
KR20150059132A (ko) 2015-05-29
IN2014DE00193A (enExample) 2015-05-01
MX347669B (es) 2017-05-08
MY180106A (en) 2020-11-23
AU2014202041A1 (en) 2015-05-14
PH12014501453A1 (en) 2015-01-21
CO7020846A2 (es) 2014-08-11
US9066926B2 (en) 2015-06-30
BR112014011741A2 (pt) 2017-05-30
CA2846644C (en) 2018-05-01
CA2846644A1 (en) 2015-07-13
AU2014202041B2 (en) 2019-11-28

Similar Documents

Publication Publication Date Title
KR20150059132A (ko) 비관절염 포유동물의 운동으로 유발된 관절 통증을 감소시키는 방법
Buford (Dis) Trust your gut: the gut microbiome in age-related inflammation, health, and disease
Rahman et al. The potential role of probiotics in the management of osteoarthritis pain: current status and future prospects
JP6426265B2 (ja) 細菌株を含む組成物
Sood et al. The probiotic preparation, VSL# 3 induces remission in patients with mild-to-moderately active ulcerative colitis
JP2014506254A (ja) β−ヒドロキシ−β−メチルブチレートを用いる廃用期間後の筋肉回復を促進させるための方法
JP2019110899A (ja) 軟骨破壊における使用のための組成物
JP2021502327A (ja) オレウロペインの生物変換
JP6975769B2 (ja) 眼疲労の抑制又は改善用組成物
JP2021502335A (ja) オレウロペインの生物変換
AU2021104421A4 (en) Gastrointestinal health composition
KR20090127260A (ko) 신경 안정제 및 기능성 식품
US20250302889A1 (en) Ingestible Nutritive Compositions With Prebiotics, Probiotics, and Postbiotics
US20170224746A1 (en) Nutritional Support Method For Health Issues
Meyerhoff et al. Common Discomforts of Pregnancy
Wibowo et al. The status of probiotics supplementation during pregnancy
Spinks et al. In vivo osteoinduction: Evaluating 2-beta coxatene as an immunoinductive compound and novel ingredient for joint support
US12208073B2 (en) Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (HMB) for enhancing recovery from soft tissue trauma
US20250367146A1 (en) Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (hmb) for enhancing recovery from soft tissue trauma
JP2017193501A (ja) 関節の痛みを改善するための組成物
Lucius Inflammatory Diseases
Ibraeva et al. Probiotics as additional treatment of Rheumatoid arthritis. A review
JP2023533191A (ja) 腸内細菌叢におけるコプロコッカス属菌（Ｃｏｐｒｏｃｏｃｃｕｓ ｓｐｐ．）の菌数を増加させる方法
WALSH Topical May Be Oral Agent OA Alternative
Williams et al. Probable inflammatory bowel disease in a child: assessment and conservative management

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R15-X000 Change to inventor requested

St.27 status event code: A-3-3-R10-R15-oth-X000

R16-X000 Change to inventor recorded

St.27 status event code: A-3-3-R10-R16-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PX0901 Re-examination

St.27 status event code: A-2-3-E10-E12-rex-PX0901

PX0701 Decision of registration after re-examination

St.27 status event code: A-3-4-F10-F13-rex-PX0701

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20190918

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R14-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 10